APA (7th ed.) Citation

AJ, M., L, O., B, B., L, K., S, M., A, B., . . . A, B. (2023). TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis. Therapeutic advances in medical oncology, 15, 17588359231152844. https://doi.org/10.1177/17588359231152844

Chicago Style (17th ed.) Citation

AJ, Medford, et al. "TRK Inhibitor in a Patient with Metastatic Triple-negative Breast Cancer and NTRK Fusions Identified via Cell-free DNA Analysis." Therapeutic Advances in Medical Oncology 15 (2023): 17588359231152844. https://doi.org/10.1177/17588359231152844.

MLA (9th ed.) Citation

AJ, Medford, et al. "TRK Inhibitor in a Patient with Metastatic Triple-negative Breast Cancer and NTRK Fusions Identified via Cell-free DNA Analysis." Therapeutic Advances in Medical Oncology, vol. 15, 2023, p. 17588359231152844, https://doi.org/10.1177/17588359231152844.